Literature DB >> 25518376

[Disruption of blood-brain barrier in multiple sclerosis and neuromyelitis optica].

Fumitaka Shimizu, Takashi Kanda.   

Abstract

Pathological destruction of the blood-brain barrier(BBB) has been considered to be the initial key step of disease process in multiple sclerosis (MS) and neuromyelitis optica (NMO). The pathological findings using autopsy brain section from patients with secondary progressive (SP) MS or relapsing MS demonstrated a leaky BBB in active lesions and our recent data also showed that the sera from patients with relapsing MS or SPMS can induce the BBB breakdown. Recently, the disease-specific autoantibody "anti-aquaporin 4(AQP4) antibodies" was detected in the sera of NMO patients. Because the circulating anti-AQP4 antibodies need to pass through BBB in order to reach the astrocytic endfeets, where AQP4 localized, our recent studies demonstrated the detailed molecular mechanism of the BBB disruption in NMO.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25518376

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  3 in total

1.  ZO-1 expression is suppressed by GM-CSF via miR-96/ERG in brain microvascular endothelial cells.

Authors:  Hu Zhang; Shuhong Zhang; Jilin Zhang; Dongxin Liu; Jiayi Wei; Wengang Fang; Weidong Zhao; Yuhua Chen; Deshu Shang
Journal:  J Cereb Blood Flow Metab       Date:  2017-04-21       Impact factor: 6.200

2.  Helicobacter pylori infection, dementia and primary open-angle glaucoma: are they connected?

Authors:  Fani Tsolaki; Jannis Kountouras; Fotios Topouzis; Magda Tsolaki
Journal:  BMC Ophthalmol       Date:  2015-03-11       Impact factor: 2.209

3.  A new technology for increasing therapeutic protein levels in the brain over extended periods.

Authors:  Ryosuke Nakano; Sayaka Takagi-Maeda; Yuji Ito; Satoshi Kishimoto; Tomoko Osato; Kaori Noguchi; Kana Kurihara-Suda; Nobuaki Takahashi
Journal:  PLoS One       Date:  2019-04-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.